Edition:
United States

Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.06USD
17 Aug 2017
Change (% chg)

$-0.00 (-2.62%)
Prev Close
$0.07
Open
$0.06
Day's High
$0.06
Day's Low
$0.06
Volume
139,223
Avg. Vol
91,781
52-wk High
$4.00
52-wk Low
$0.02

GTHP.OB

Chart for GTHP.OB

About

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including... (more)
No analyst recommendations are available for GTHP.OB.

Overall

Beta: 0.08
Market Cap(Mil.): $0.12
Shares Outstanding(Mil.): 1.83
Dividend: --
Yield (%): --

Financials

  GTHP.OB Industry Sector
P/E (TTM): -- 120.44 32.84
EPS (TTM): -59.21 -- --
ROI: -- 9.39 14.86
ROE: -- 14.54 16.11

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $61.81 -0.89
GlaxoSmithKline plc (GSK.L) 1,506.00 --
Hologic, Inc. (HOLX.OQ) $37.95 -0.26
Qiagen NV (QGEN.OQ) $31.44 -0.03
SpectraScience Inc (SCIE.PK) $0.00 +0.00

Earnings vs. Estimates

No consensus analysis data available.